Guerin Mark Patrick Insider Trading
Get the latest insider transactions of Guerin Mark Patrick. Guerin Mark Patrick is Chief Accounting Officer in Onconova Therapeutics, Inc. ($ONTX) and Chief Financial Officer in Onconova Therapeutics, Inc. ($ONTX). Discover the current value of Guerin Mark Patrick shares.
Address: C/O ONCONOVA THERAPEUTICS, INC. 375 PHEASANT RUN NEWTOWN 18940PA
Guerin Mark Patrick is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| ONTX | Onconova Therapeutics, Inc. | Chief Financial Officer, Chief Accounting Officer | 145,213 | 389,170.84 |
Insider Trading Transactions of Guerin Mark Patrick
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 1.51 | 301,000 | 454,510 | 301,000 |
| Feb 17 2021 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Buy | 1.00 | 15,000 | 15,000 | 145,213 |
| Nov 30 2020 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Buy | 0.26 | 16,755 | 4,356 | 125,599 |
| Nov 30 2020 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Buy | 0.26 | 4,614 | 1,200 | 130,213 |
| Jul 10 2020 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 0.56 | 543,000 | 304,080 | 543,000 |
| May 20 2020 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Buy | 0.36 | 21,000 | 7,560 | 108,844 |
| Dec 26 2019 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 0.31 | 65,000 | 20,150 | 65,000 |
| Nov 26 2019 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Buy | 0.20 | 87,500 | 17,500 | 87,844 |
| Nov 26 2019 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 0.20 | 87,500 | 17,500 | 87,500 |
| Jul 30 2018 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 0.46 | 384,950 | 177,077 | 384,950 |
| Jan 05 2018 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 1.50 | 31,024 | 46,536 | 31,024 |
| Apr 28 2017 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Buy | 2.10 | 1,429 | 3,001 | 5,155 |
| Jan 19 2017 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 2.70 | 19,413 | 52,415 | 19,413 |
| Dec 19 2016 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 2.65 | 5,587 | 14,806 | 5,587 |
| Sep 01 2016 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 3.24 | 10,000 | 32,400 | 10,000 |
| Sep 01 2016 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Financial Offic ... | Option Exercise | 3.24 | 5,000 | 16,200 | 5,000 |
| Aug 10 2016 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Accounting Offi ... | Buy | 4.10 | 3,666 | 15,031 | 3,726 |
| Aug 10 2016 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Accounting Offi ... | Option Exercise | 4.10 | 90 | 369 | 0 |
| Aug 10 2016 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Accounting Offi ... | Option Exercise | 4.92 | 2,749 | 13,525 | 2,749 |
| Jan 28 2016 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Accounting Offi ... | Option Exercise | 0.65 | 46,809 | 30,426 | 46,809 |
| Oct 01 2015 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Accounting Offi ... | Option Exercise | 1.48 | 17,500 | 25,900 | 17,500 |
| Apr 20 2015 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Accounting Offi ... | Option Exercise | 2.32 | 15,000 | 34,800 | 15,000 |
| Dec 22 2014 | ONTX | Onconova Therapeutics, In ... | Guerin Mark Patrick | Chief Accounting Offi ... | Option Exercise | 3.98 | 25,000 | 99,500 | 25,000 |